Literature DB >> 25651335

Influenza virus surveillance by the Instituto Adolfo Lutz, influenza season 2014: antiviral resistance.

Katia Corrêa de Oliveira Santos1, Daniela Bernardes Borges da Silva1, Margarete Aparecida Benega1, Renato de Sousa Paulino1, Elian Reis e Silva1, Dejanira dos Santos Pereira2, Aparecida Duarte Hg Mussi2, Valéria Cristina da Silva1, Larissa V Gubareva3, Terezinha Maria de Paiva1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25651335      PMCID： PMC4325532          DOI： 10.1590/S0036-46652015000100016

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN： 0036-4665            Impact factor:   1.846


× No keyword cloud information.
  6 in total

Review 1.  Influenza genome analysis using pyrosequencing method: current applications for a moving target.

Authors:  Varough M Deyde; Larisa V Gubareva
Journal:  Expert Rev Mol Diagn       Date:  2009-07       Impact factor: 5.225

Review 2.  Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors.

Authors:  Margaret Okomo-Adhiambo; Tiffany G Sheu; Larisa V Gubareva
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

3.  Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Authors:  Tiffany G Sheu; Varough M Deyde; Margaret Okomo-Adhiambo; Rebecca J Garten; Xiyan Xu; Rick A Bright; Eboneé N Butler; Teresa R Wallis; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

4.  Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil.

Authors:  Camila Marx; Tatiana Schäffer Gregianini; Fernanda Kieling Moreira Lehmann; Vagner Ricardo Lunge; Silvia de Carli; Bibiana Paula Dambrós; Gabriela Luchiari Tumioto; Claudete Seadi; André Salvador Kazantzi Fonseca; Nilo Ikuta
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

5.  Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.

Authors:  Jeff Butler; Kathryn A Hooper; Stephen Petrie; Raphael Lee; Sebastian Maurer-Stroh; Lucia Reh; Teagan Guarnaccia; Chantal Baas; Lumin Xue; Sophie Vitesnik; Sook-Kwan Leang; Jodie McVernon; Anne Kelso; Ian G Barr; James M McCaw; Jesse D Bloom; Aeron C Hurt
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823

6.  Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out?

Authors:  Thiago Moreno L Souza; Paola C Resende; Natalia Fintelman-Rodrigues; Tatiana Schaffer Gregianini; Nilo Ikuta; Sandra Bianchini Fernandes; Ana Luisa Furtado Cury; Maria do Carmo Debur Rosa; Marilda M Siqueira
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.